Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials

doi:10.4252/wjsc.v12.i6.471

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11266)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

731

WORD

183

HTML

5986

Figures (1-2)

527

Tables (1-1)

303

Sum=7730

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

477

Download

903

Sum=1380

Publishing Process of This Article

Item

Count

Browse

724

Download

1432

Sum=2156

Jun 26, 2020 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Jun 26, 2020; 12(6): 471-480
Published online Jun 26, 2020. doi: 10.4252/wjsc.v12.i6.471

Full Size Figure Download Figure

Figure 1 Characteristics of clinical trials. A: Clinical phases; B: Status of trials; C: Chronological distribution; D: Geographical locations. CAN: Canada; BRZ: Brazil; EUR: Europe; EGY: Egypt; IR: Iran; RUS: Russia; CHN: China; VNM: Vietnam; AUS: Australia; Pana: Panama; JO: Jordan.

Citation: Ji HL, Liu C, Zhao RZ. Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials. World J Stem Cells 2020; 12(6): 471-480
URL: https://www.wjgnet.com/1948-0210/full/v12/i6/471.htm
DOI: https://dx.doi.org/10.4252/wjsc.v12.i6.471